Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.03.2024 | Case report

Adalimumab/methotrexate

Eosinophilic pneumonitis and eosinophilic pneumonia

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Patel A, et al. An Unusual Case of Acute Eosinophilic Lung Disease in the Setting of Adalimumab Use. American Journal of Respiratory and Critical Care Medicine 207: May 2023. Available from: URL: https://dx.doi.org/10.1164/ajrccm-conference.2023.B36 [abstract] Patel A, et al. An Unusual Case of Acute Eosinophilic Lung Disease in the Setting of Adalimumab Use. American Journal of Respiratory and Critical Care Medicine 207: May 2023. Available from: URL: https://dx.doi.org/10.1164/ajrccm-conference.2023.B36 [abstract]
Metadaten
Titel
Adalimumab/methotrexate
Eosinophilic pneumonitis and eosinophilic pneumonia
Publikationsdatum
01.03.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-53863-8

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Multiple drugs

Case report

Anastrozole

Case report

Bosutinib

Case report

Multiple drugs

Case report

Heparin